Antioxidant system state in patients with multiple sclerosis current in therapy

Biomeditsinskaya Khimiya

Volumn 57, Issue 6, 2011, Pages 661-670

  Smirnova, L P ^a   Krotenko, N V ^b   Grishko, E V ^a   Krotenko, N M ^b   Alifirova, V M ^a   Ivanova, S A ^b  

^a MENTAL HEALTH RESEARCH INSTITUTE   (Russian Federation)

^b SIBERIAN STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Antioxidant enzymes; Multiple sclerosis; Oxidative stress

Indexed keywords

ANTIOXIDANT; GLATIRAMER; IMMUNOLOGICAL ADJUVANT; MALONALDEHYDE; PEPTIDE;

ADULT; ARTICLE; BLOOD; CASE CONTROL STUDY; DRUG EFFECT; ENZYMOLOGY; ERYTHROCYTE; HUMAN; IMMUNOLOGY; LIPID PEROXIDATION; METABOLISM; MULTIPLE SCLEROSIS; OXIDATIVE STRESS; TIME;

ADJUVANTS, IMMUNOLOGIC; ADULT; ANTIOXIDANTS; CASE-CONTROL STUDIES; ERYTHROCYTES; HUMANS; LIPID PEROXIDATION; MALONDIALDEHYDE; MULTIPLE SCLEROSIS; OXIDATIVE STRESS; PEPTIDES; TIME FACTORS;

EID: 84862334487     PISSN: 23106905     EISSN: None     Source Type: Journal    
DOI: 10.18097/pbmc20115706661     Document Type: Article

References (6)

1. Gilgun-Sherki Y., Melamed E., Offen D. (2004) J. Neurol., 251(3), 261-268.
2. Little C. (1968) Biochem. Biophys. Res. Commun., 31, 145-150.
3. Carbery J., Mannervick B. (1975) J. Biol. Chem., 250, 5475-5480.
4. Keen J. H. (1976) J. Biol. Chem., 251, 6183-6188.
5. Bredford M. (1976) Anal. Biochem., 72, 248-354.
6. Beckman K. B., Ames B. N. (1998) Physiol. Rev., 78, 547-581.